YN250377 HSV-TK substrate 111687-37-7

HSV-TK substrate is a substrate for HSV-TK, and induces multi-log cytotoxicity in HSV-TK-expressing and byst and er cells. HSV-TK substrate shows antitumor activity.

YN251886 BRL44385 114778-60-8

BRL44385 is a potent and selective inhibitor of the replication of herpes simplex virus types 1 and 2 (HSV-1 and HSV2), varicella zoster virus (VZV) and Epstein-Barr virus (EBV).

YN250250 Omaciclovir 124265-89-0

Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity.

YN250718 Valacyclovir 124832-26-4

Valacyclovir (Valaciclovir) is an orally activeantiviraldrug for herpes simplex, herpes zoster, and herpes B. Valacyclovir inhibitsHSV-1W (50=2.9 μg/ml). Valacyclovir is a prodrug of Aciclovir (HY-17422) .

YN250719 Valacyclovir hydrochloride 124832-27-5

Valaciclovir HCl, an aciclovir prodrug, inhibits activity of virus DNA polymerase, used to treat infections caused by herpes simplex virus (HSV) and varicella zoster virus, and for prophylaxis against cytomegalovirus (CMV).

YN250629 Pritelivir 348086-71-5

Pritelivir (BAY 57-1293) is a potent helicase primase inhibitor, exhibiting antiviral effect on herpes simplex virus (HSV) with IC50 of 20 nM for both HSV-1 and HSV-2.

YN250599 Amenamevir 841301-32-4

Amenamevir is a potent helicase-primase inhibitor and a novel class of antiviral agent.

YN250393 LDC4297 1453834-21-3

LDC4297 is a novel CDK7 inhibitor (IC50=0.13±0.06 nM for CDK7 versus IC50s between 10 nM and 10,000 nM for all other analyzed CDKs).